Theranostics 2017; 7(5):1192-1203. doi:10.7150/thno.17881

Research Paper

Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression

Gan Liu1,2*, Hsiang-i Tsai1,2*, Xiaowei Zeng1,2*, Yixiong Zuo1,2, Wei Tao1,2, Jun Han3, Lin Mei1,2✉

1. The Shenzhen Key Lab of Gene and Antibody Therapy and Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China;
2. School of Life Sciences, Tsinghua University, Beijing 100084, PR China;
3. Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P.R.China.
* These three authors contributed equally to this work.

Abstract

The efficient delivery of anticancer drugs into tumor tissues to improve therapeutic efficacy remains an urgent demand. To satisfy this demand, a drug delivery system based on a stealthy nanocapsule was developed. This nanocapsule was fabricated by encapsulating stealthy cross-linked poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and benzaldehyde groups around the protein bovine serum albumin (BSA) followed by conjugation of doxorubicin (Dox) through a pH-responsive benzoic-imine bond. The in vitro results show that the Dox-conjugated nanocapsule (nBSA-Dox) released the drug under an acidic tumor microenvironment (pH ~6.5) and killed HepG2 human liver cancer cells. The half-life of Dox conjugated to nBSA in mice was significantly prolonged, and the area-under-curve of plasma Dox of the mice treated with nBSA-Dox was as much as 242 fold of free Dox. The in vivo results confirmed that this nanocapsule efficiently accumulated in tumor tissue and significantly suppressed the tumor growth.

Keywords: stealthy nanocapsule, tumor suppression, phosphorylcholine, tumor microenvironment, benzoic-imine bond.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Liu G, Tsai Hi, Zeng X, Zuo Y, Tao W, Han J, Mei L. Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression. Theranostics 2017; 7(5):1192-1203. doi:10.7150/thno.17881. Available from http://www.thno.org/v07p1192.htm